Guided Therapeutics (GTHP) Total Current Liabilities (2010 - 2026)
Guided Therapeutics (GTHP) posted Total Current Liabilities of $6.6 million for Q4 2025, up 2.57% sequentially from $6.5 million in Q3 2025, and up 7.81% YoY from $6.2 million in Q4 2024.
Guided Therapeutics (GTHP) Total Current Liabilities (2010 - 2026) Analysis & Trends
Guided Therapeutics has reported Total Current Liabilities for 16 years, with the latest figure at $6.6 million in Q4 2025.
- Quarterly Total Current Liabilities rose 7.81% year-over-year to $6.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.6 million (up 7.81% YoY) and the FY2025 annual result came in at $6.6 million, up 7.81% from the prior year.
- Total Current Liabilities improved to $6.6 million in Q4 2025 per GTHP's latest filing, from $6.5 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $9.2 million in Q1 2021 and troughed at $4.0 million in Q1 2023.
- A 5-year average of $5.7 million and a median of $5.7 million in 2021 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2022 and 2024: Total Current Liabilities tumbled 40.96% in 2022, then jumped 33.45% in 2024.
- Over 5 years, Total Current Liabilities stood at $5.7 million in 2021, then retreated by 14.49% to $4.9 million in 2022, then slipped by 1.23% to $4.8 million in 2023, then rose by 27.99% to $6.2 million in 2024, then gained by 7.81% to $6.6 million in 2025.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $6.6 million, $6.5 million, and $6.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 17.81 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 6.68 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 6.43 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 1.51 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 2.36 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 8.30 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 8.63 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 1.28 Bn |
| 10 | Guided Therapeutics | 26.06 Mn | 26.05 Mn | - | 6.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.17 Mn |
| Dec 31, 2025 | 6.64 Mn |
| Sep 30, 2025 | 6.47 Mn |
| Jun 30, 2025 | 6.38 Mn |
| Mar 31, 2025 | 5.90 Mn |
| Dec 31, 2024 | 6.16 Mn |
| Sep 30, 2024 | 6.03 Mn |
| Jun 30, 2024 | 5.73 Mn |
| Mar 31, 2024 | 5.34 Mn |
| Dec 31, 2023 | 4.81 Mn |
| Sep 30, 2023 | 4.83 Mn |
| Jun 30, 2023 | 4.94 Mn |
| Mar 31, 2023 | 4.00 Mn |
| Dec 31, 2022 | 4.87 Mn |
| Sep 30, 2022 | 5.15 Mn |
| Jun 30, 2022 | 6.00 Mn |
| Mar 31, 2022 | 5.45 Mn |
| Dec 31, 2021 | 5.69 Mn |
| Sep 30, 2021 | 5.08 Mn |
| Jun 30, 2021 | 5.67 Mn |